This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/Dihydrocodeine: Difference between revisions
Jump to navigation
Jump to search
>Rhz m Text replacement - "(\|)([A-Za-z]+)ROA_Strong=[ ]*([0-9.]+)[- ]+([0-9.]+)[ ]*([muµ]g)" to "$1$2ROA_Strong=$2 strong min dose::$3 - $2 strong max dose::$4 $5" |
>Rhz m Text replacement - "([A-Za-z]+) ([a-z]+) min dose" to "$1 min $2 dose" |
||
| Line 54: | Line 54: | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability= | ||
|OralROA_Threshold=[[Oral threshold dose::20]] - 50 [[Oral dose units::mg]] | |OralROA_Threshold=[[Oral threshold dose::20]] - 50 [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral light | |OralROA_Light=[[Oral min light dose::50]] - [[Oral light max dose::100]] mg | ||
|OralROA_Common=[[Oral min common dose::100]] - [[Oral max common dose::150]] mg | |OralROA_Common=[[Oral min common dose::100]] - [[Oral max common dose::150]] mg | ||
|OralROA_Strong=[[Oral strong | |OralROA_Strong=[[Oral min strong dose::150]] - [[Oral strong max dose::200]] mg | ||
|OralROA_Heavy=[[Oral heavy dose::200]] mg + | |OralROA_Heavy=[[Oral heavy dose::200]] mg + | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
Revision as of 02:17, 9 May 2016
| SubstanceBox/Dihydrocodeine | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||||||||||||||||||
 |
|||||||||||||||||||||||||
| Chemical Nomenclature | |||||||||||||||||||||||||
| Common names | Dihydrocodeine | ||||||||||||||||||||||||
| Systematic name | 4,5-alpha-epoxy-3-methoxy-17-methylmorphinan-6-ol | ||||||||||||||||||||||||
| Class Membership | |||||||||||||||||||||||||
| Psychoactive class | Opioid | ||||||||||||||||||||||||
| Chemical class | Morphinan | ||||||||||||||||||||||||
| Routes of Administration | |||||||||||||||||||||||||
|
|||||||||||||||||||||||||